Search Kailos website
November 2, 2020
There are few, if any, aspects of daily life that haven’t been altered in some way by the COVID-19 (COVID) pandemic. Whether we are grocery shopping or visiting the clinic, virus mitigation measures such as social distancing and mask wearing have been added to our routines to defend against a health threat we cannot see.
Huntsville, Ala. - October 2020 - Huntsville Hospital Health System (HH Health System) and Kailos Genetics, a HudsonAlpha Resident Company, are pleased to announce a partnership to offer Assure SentinelTM testing for COVID-19 to North Alabama.
Kailos Genetics announces the launch of Assure Sentinel, a first-of-its-kind workplace viral suppression program that tests organizations for COVID-19 on a frequent and recurring basis.
Huntsville Hospital Health System (HH Health System) and Kailos Genetics, a HudsonAlpha Resident Company, are pleased to announce a partnership to offer Assure SentinelTM testing for COVID-19 to North Alabama.
October 30, 2020
No one ever said geneticists couldn’t have a sense of humor.
Back in 1984, Christiane Nüsslein-Volhard and her collaborator, Gerd Jürgens, published a study identifying and naming a number of embryonic lethal Drosophila mutants from a large-scale mutation screen that caused a variety of deformities.
Everyone’s genes have natural variations known as mutations. Most of these variations are not harmful and are responsible for traits like height and eye color. However, there are some variations, called “pathogenic” mutations, that are known to increase a person’s risk of developing disease. These pathogenic mutations, because they are located in a person’s genes, can then be passed from parent to child, creating heritable forms of disease, such as cancer.